ACTR-53. INTERIM ANALYSIS OF PHASE 1B/2 COMBINATION STUDY OF THE IDO PATHWAY INHIBITOR INDOXIMOD WITH TEMOZOLOMIDE FOR ADULT PATIENTS WITH TEMOZOLOMIDE-REFRACTORY PRIMARY MALIGNANT BRAIN TUMORS

Abstract

Open access

Peer reviewed

Yousef Zakharia, David Munn, Charles Link, Nicholas Vahanian and Eugene Kennedy

Neuro-oncology (Charlottesville, Va.), Vol.18(suppl_6), pp.vi13-vi14

11/01/2016

DOI: 10.1093/neuonc/now212.051

Files and links (1)

url

https://doi.org/10.1093/neuonc/now212.051View

Published (Version of record) Open Access

Title: Subtitle: ACTR-53. INTERIM ANALYSIS OF PHASE 1B/2 COMBINATION STUDY OF THE IDO PATHWAY INHIBITOR INDOXIMOD WITH TEMOZOLOMIDE FOR ADULT PATIENTS WITH TEMOZOLOMIDE-REFRACTORY PRIMARY MALIGNANT BRAIN TUMORS
Creators: Yousef Zakharia - University of Iowa
David Munn - Augusta University Health
Charles Link - NewLink Genetics
Nicholas Vahanian - NewLink Genetics
Eugene Kennedy - NewLink Genetics
Resource Type: Abstract
Publication Details: Neuro-oncology (Charlottesville, Va.), Vol.18(suppl_6), pp.vi13-vi14
DOI: 10.1093/neuonc/now212.051
ISSN: 1522-8517
eISSN: 1523-5866
Language: English
Date published: 11/01/2016
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
Record Identifier: 9984548377802771

2 Record Views